Strattera Improves ADHD and Reading Disorders

New data suggest that Strattera improved ADHD symptoms in children and adolescents who had both ADHD and a reading disorder like dyslexia. Results were announced today, October 27, 2006 at a meeting of child and adolescent psychiatrists.

The primary objective of the study was to measure Strattera's efficacy in treating the symptoms of ADHD in children and adolescents with ADHD and reading disorders.

After taking Strattera for 16 weeks, both groups of patients 10 to 16 years of age reported an improvement of nearly 50 percent in ADHD symptoms like inattentiveness, hyperactivity, and impulsivity. Additionally, patients with ADHD+ reading disorders displayed an average reading composite improvement of approximately two years compared to 17 months for participants with ADHD alone.

The two most common developmental disabilities of school-age children are ADHD and learning disabilities, including reading disorders. It is estimated that 15-30 percent of children with ADHD will also have a reading disorder. (Yahoo)